http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8606899-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c163c101399a77181408b93dc02fe00d |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
filingDate | 1985-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1986-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-8606899-A1 |
titleOfInvention | 2 HUMAN INTERLEUKIN PRODUCTION IN STREPTOMYCES |
abstract | PROCEDURE FOR THE PRODUCTION OF HUMAN INTERLEUQUIN 2. IT INCLUDES: A) CULTIVATING STREPTOMYCES CELLS UNDER AEROBIC CONDITIONS, IN THE MEDIUM CALLED YEME AT 28JC DURING 5 TO 7 DAYS AT 200 RPM, IN THE PRESENCE OF THE ANTIBIOTIC THIOESTREPTON IN QUANTITIES OF 50 G / ML, TRANSFORMED WITH A PLAS IN THE IT CODES FOR HUMAN INTERLEUQUIN 2 WHERE THE GENE THAT CODES FOR HUMAN INTERLEUQUIN 2 IS CLONED IN A PLASMIDIC VECTOR OF S. LIVIDANS THAT CONTAINS TRANSCRIPTION AND TRANSLATION SIGNALS OF E. COLI AND THE GENE THAT CODES FOR INTERLEUQUIN 2 IS EXPRESSED A SYNTHETIC PROMOTER AND A SITE OF UNION TO THE SYNTHETIC RIBOSOME; AND B) ISOLATE THE HUMAN INTERLEUQUIN 2 PRODUCED IN THE MEDIUM BY ELECTROPHORESIS IN POLYACRYLAMIDE GEL. IT IS USED FOR CLINICAL USE AS A POTENTIAL OF IMMUNE RESPONSES, BOTH CELLULAR AND HUMORAL IN NORMAL STATES OR IN STATES OF IMMUNODEFICIENCY AND AUTOIMMUNE DISEASES.- |
priorityDate | 1985-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.